Sodium Carbonate → HCID 178480967, compound

HRID 897536Notes

Reaction equation

HRID 897536 reaction equation
I[C:2]1[C:10]2[C:5](=[N:6][CH:7]=[N:8][C:9]=2[NH2:11])[N:4]([C@H:12]2[CH2:17][CH2:16][C@@H:15]([N:18]3[CH2:23][CH2:22][N:21]([CH3:24])[CH2:20][CH2:19]3)[CH2:14][CH2:13]2)[N:3]=1.CC1(C)C(C)(C)OB([C:33]2[CH:38]=[CH:37][C:36]([NH:39][C:40]3[N:44]([CH3:45])[C:43]4[CH:46]=[CH:47][CH:48]=[CH:49][C:42]=4[N:41]=3)=[CH:35][CH:34]=2)O1.C(=O)([O-])[O-].[Na+].[Na+]>COCCOC.O.[Pd].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>[CH3:45][N:44]1[C:43]2[CH:46]=[CH:47][CH:48]=[CH:49][C:42]=2[N:41]=[C:40]1[NH:39][C:36]1[CH:37]=[CH:38][C:33]([C:2]2[C:10]3[C:5](=[N:6][CH:7]=[N:8][C:9]=3[NH2:11])[N:4]([C@H:12]3[CH2:17][CH2:16][C@@H:15]([N:18]4[CH2:23][CH2:22][N:21]([CH3:24])[CH2:20][CH2:19]4)[CH2:14][CH2:13]3)[N:3]=2)=[CH:34][CH:35]=1

Participants

7

Reactant 3

HCID 10340Sodium CarbonateHCID 223472511-Methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-benzo[d]imidazol-2-amineHCID 178481014HCID 178481014, compound

Product 1

HCID 178480967HCID 178480967, compoundYield 50.1%

Reagents, catalysts & solvents 3

HCID 11979704Tetrakis(triphenylphosphine)palladiumCatalystHCID 962WaterSolventHCID 80711,2-DimethoxyethaneSolvent

Conditions

Temperature
83 °C

Procedure

To a solution of cis-3-iodo-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine (0.100 g, 0.227 mmol) in ethylene glycol dimethyl ether (3 mL) and water (1.5 mL) under nitrogen was added N2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-methyl-1H-benzo[d]imidazol-2-amine (0.099 g, 0.28 mmol), tetrakis(triphenylphosphine) palladium (0) (0.013 mg, 0.011 mmol), and sodium carbonate (0.060 mg, 0.568 mmol). The solution was stirred at 83° C. for 15 h. The resulting yellow mixture was concentrated in vacuo to give a yellow oil. Purification by preparative HPLC (25 to 100% CH3CN in 0.1 N aqueous ammonium acetate over 20 min at 21 mL/min using a 8μ Hypersil HS C18, 250×21 mm column, tr=7.3-11.2 min.) afforded cis-3-{4-[(1-methyl-1H-benzo[d]imidazol-2-yl)amino]phenyl}-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine as an off-white solid (0.061 g, 50%): 1H NMR (DMSO-d6, 400 MHz) δ 9.17 (s, 1H), 8.23 (s, 1H), 8.08 (d, 2H), 7.62 (d, 2H), 7.42 (m, 1H), 7.33 (m, 1H), 7.08 (m, 1H), 4.80 (m, 1H), 3.76 (s, 3H), 2.50-2.07 (m, 12H), 1.80-1.60 (m, 8H); RP-HPLC (25 to 100% CH3CN in 0.1 N aqueous ammonium acetate over 10 min at 1 mL/min using a Hypersil HS C18, 250×4.6 mm column) tr=5.92 min., 99%; m/z 537 (MH+).

Workup

  1. concentrationThe resulting yellow mixture was concentrated in vacuo
  2. customto give a yellow oil
  3. customPurification by preparative HPLC (25 to 100% CH3CN in 0.1 N aqueous ammonium acetate over 20 min at 21 mL/min
  4. customa 8μ Hypersil HS C18, 250×21 mm column, tr=7.3-11.2 min.

Sources & evidence

ORD record
ord-60f3873dc0994b62a57691ff6186db54
Source dataset
uspto-grants-2005_07
Patent number
US06921763B2

Reaction notes

Loading…